Lidocaine Hydrochloride and Epinephrine
- Product NDC
- 84549-182
- Requested package NDC
- 84549-182-03
- 11-digit product format
- 845490182
- Labeler code
- 84549
- Product ID
- 84549-182_463ecfc4-b5fa-62dd-e063-6294a90a9404
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LIDOCAINE HYDROCHLORIDE and EPINEPHRINE
- Dosage form
- INJECTION, SOLUTION
- Route
- INFILTRATION; PERINEURAL
- Labeler
- ProPharma Distribution
- Application
- ANDA089646
- Marketing category
- ANDA
- Marketing start
- 2005-06-23
- Substance
- EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
- Active strength
- 10; 20 ug/mL; mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A089646-001 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.01MG/ML;2% | INJECTABLE / INJECTION | RS | 1988-06-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A089646-001 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | RS | 1988-06-21 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 2f94f711-14c4-48ec-c5a3-c5ec4b8e8729 | 2026-06-24 | Warnings, Adverse reactions | 089646 ANDA089646 |
| LIDOCAINE HCl AND EPINEPHRINE | LIDOCAINE HCL AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a09613b2-4337-5b52-e053-2995a90ab74b | 2026-06-19 | Warnings, Adverse reactions | 089646 ANDA089646 |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | ProPharma Distribution | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2025-12-18 | Warnings, Adverse reactions | 089646 ANDA089646 84549-182-03 84549-182 84549018203 |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | e0e621d2-10b0-4cdf-b31d-c19b1e86ba6b | 2025-06-03 | Warnings, Adverse reactions | 089646 ANDA089646 |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 5692e28d-559c-4b6a-8421-fa85d7155818 | 2025-02-21 | Warnings, Adverse reactions | 089646 ANDA089646 |
| LIDOCAINE HCl AND EPINEPHRINE | LIDOCAINE HCL AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a098ab6c-143f-77a5-e053-2a95a90a3e0a | 2024-02-22 | Warnings, Adverse reactions | 089646 ANDA089646 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lidocaine Hydrochloride and Epinephrine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 10 ug/mL |
| EPINEPHRINE | 20 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
| YKH834O4BH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1010759 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 43048b6b-3c83-eef4-e063-6294a90a34cb | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84549-182-03 | Lidocaine Hydrochloride and Epinephrine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 2 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1010759 | lidocaine HCl 2 % / EPINEPHrine 1:100,000 Injectable Solution | PSN | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2 |
| 1010759 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution | SCD | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2 |
| 1010759 | epinephrine (as epinephrine bitartrate) 1:100,000 / lidocaine hydrochloride 2 % Injectable Solution | SY | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2 |
| 1010759 | epinephrine 1:100,000 / lidocaine hydrochloride 2 % Injectable Solution | SY | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 84549-182-03 | 84549018203 | 50 mL in 1 VIAL, MULTI-DOSE (84549-182-03) | 50 ml | 2025-10-10 | No | No | Current |